|
End-of-day quote
Other stock markets
|
||
| - EUR | - |
|
15.06.2011
IPSOGEN S.A. (Alternext: ALIPS, ISIN: FR0010626028), Cancer Profiler, who develops, manufactures and commercializes molecular diagnostic assays for leukemia and breast cancer announces today that QIAGEN (NASDAQ: QGEN; Frankfurt, Prime Standard: QIA) has made an offer and entered into exclusive negotiations to purchase a 47% initial stake in IPSOGEN S.A. and subsequently make a voluntary public offer to fully acquire the outstanding shares of IPSOGEN S.A.
| 1st Jan change | Capi. | |
|---|---|---|
| -27.70% | 9.87B | |
| +27.06% | 2.89B | |
| -16.78% | 2.75B | |
| -15.31% | 2.13B | |
| -21.41% | 1.65B | |
| +68.70% | 1.47B | |
| +29.75% | 811M | |
| -5.02% | 733M | |
| -29.39% | 510M |
QIAGEN MARSEILLE 
By 
